Fresenius Medical Care AG (ETR:FME – Get Free Report)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of €38.44 ($39.63) and traded as high as €44.15 ($45.52). Fresenius Medical Care shares last traded at €43.51 ($44.86), with a volume of 458,800 shares changing hands.
Fresenius Medical Care Stock Up 0.1 %
The business has a fifty day simple moving average of €42.61 and a 200 day simple moving average of €38.44. The firm has a market cap of $12.78 billion, a price-to-earnings ratio of 24.07, a PEG ratio of 0.42 and a beta of 0.86. The company has a debt-to-equity ratio of 77.56, a current ratio of 1.46 and a quick ratio of 0.80.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Featured Articles
- Five stocks we like better than Fresenius Medical Care
- Top Biotech Stocks: Exploring Innovation Opportunities
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What is Insider Trading? What You Can Learn from Insider Trading
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- How to Use Stock Screeners to Find Stocks
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.